Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel Drugs for the Treatment of Diabetes Developed by Hebrew University Researcher

30.05.2003


A new approach to providing medication for adult diabetics (type 2 diabetes) that is not dependent on insulin has been developed by a doctoral student at the Hebrew University of Jerusalem. For his work, which he did for his Ph.D. thesis in pharmacology, Arie Gruzman was awarded one of this year’s Kaye Innovation Awards at the Hebrew University.


Arie Gruzman



Unlike other conventional drugs that require active insulin-producing cells in the pancreas and that often fail to overcome a companion problem of insulin resistance, the novel compounds developed by Gruzman and his supervisor, Prof. Shlomo Sasson, in collaboration with Prof. Yehoshua Katzhendler and Prof. Erol Cerasi of the Hebrew University School of Pharmacy and the Faculty of Medicine, are unique in that they can reduce hyperglycemia (above-normal levels of glucose in the blood) by increasing the rate of glucose disposal in the blood in a non-insulin-dependent manner.

The new drugs, when fully developed, may provide a treatment to diabetic patients who have especially serious problems of insufficient natural insulin production and/or resistance to insulin.


A patent for these new compounds – which, perhaps surprisingly, are based on D-Xylose, a sugar found in fruits -- has been obtained through the Hebrew University’s Yissum Research Development Company. The laboratory work was supported financially by the Deutsch Foundation of Venezuela and the Nophar Program of the Israel Ministry of Trade and Industry.

Gruzman, 32, was born in Russia and studied at a medical institute in his home town of Nizhny Novogrod. He immigrated to Israel 12 years ago and earned a B.Sc.degree in pharmaceutical chemistry at Bar-Ilan University, after which he began his graduate studies at the Hebrew University. He is married to another immigrant from the former U.S.S.R., who is a graduate student at the Hebrew University Faculty of Medicine, and they are the parents of two daughters.

The Kaye Innovation Awards at the Hebrew University have been awarded annually since 1994. Isaac Kaye of England, a prominent industrialist in the pharmaceutical industry, established the awards to encourage faculty, staff, and students of the university to develop innovative methods and inventions with good commercial potential which have benefited or will benefit the university and society. The Kaye Innovation Awards at the Hebrew University were awarded on May 27, during the 66th meeting of the University Board of Governors.

For further information: Jerry Barach, Dept. of Media Relations, the Hebrew University, 02-5864772; Orit Sulitzeanu, spokesperson, 052-608016

Jerry Barach | Hebrew University

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>